Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Elliott

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The New England Journal of Medicine|May 30, 2008
Exploiting a research underclass in phase 1 clinical trialsCarl Elliott, Roberto Abadie
Perspectives in Biology and Medicine|January 30, 2007
Ghost marketing: pharmaceutical companies and ghostwritten journal articlesBarton Moffatt, Carl Elliott
The Hastings Center Report|October 15, 2025
The Hennepin Healthcare Forced Ketamine Studies, Excited Delirium, and Police ViolenceCarl Elliott, Lauren Wilson
Journal of General Internal Medicine|August 22, 2006
Why disclosure?Raymond De Vries, Carl Elliott
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
From community to commodity: the ethics of pharma-funded social networking sites for physiciansAmy Snow Landa, Carl Elliott
Bioethics|May 26, 2010
Commentary: What's wrong with ghostwriting?Carl Elliott, Amy Snow Landa
Journal of Bioethical Inquiry|August 26, 2020
Humiliating Whistle-Blowers: Li Wenliang, the Response to Covid-19, and the Call for a Decent SocietyJing-Bao Nie, Carl Elliott
The New England Journal of Medicine|June 28, 2013
The OHRP and SUPPORT--another viewRuth Macklin, Lois Shepherd, Alice Dreger, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The New England Journal of Medicine|May 30, 2008
Exploiting a research underclass in phase 1 clinical trialsCarl Elliott, Roberto Abadie
Perspectives in Biology and Medicine|January 30, 2007
Ghost marketing: pharmaceutical companies and ghostwritten journal articlesBarton Moffatt, Carl Elliott
The Hastings Center Report|October 15, 2025
The Hennepin Healthcare Forced Ketamine Studies, Excited Delirium, and Police ViolenceCarl Elliott, Lauren Wilson
Journal of General Internal Medicine|August 22, 2006
Why disclosure?Raymond De Vries, Carl Elliott
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
From community to commodity: the ethics of pharma-funded social networking sites for physiciansAmy Snow Landa, Carl Elliott
Bioethics|May 26, 2010
Commentary: What's wrong with ghostwriting?Carl Elliott, Amy Snow Landa
Journal of Bioethical Inquiry|August 26, 2020
Humiliating Whistle-Blowers: Li Wenliang, the Response to Covid-19, and the Call for a Decent SocietyJing-Bao Nie, Carl Elliott
The New England Journal of Medicine|June 28, 2013
The OHRP and SUPPORT--another viewRuth Macklin, Lois Shepherd, Alice Dreger, et al.
Pageof 6